-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – MZE-829 in Chronic Kidney Disease (Chronic Renal Failure)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - MZE-829 in Chronic Kidney Disease (Chronic Renal Failure) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. MZE-829 in Chronic Kidney Disease (Chronic Renal Failure)...
-
Product Insights
NewPolycystic Kidney Disease – Drugs In Development, 2024
Empower your strategies with our Polycystic Kidney Disease – Drugs In Development, 2024 report and make more profitable business decisions. Polycystic kidney disease (PKD) is a disorder in which clusters of cysts develop primarily within kidneys. PKD symptoms may include high blood pressure, back or side pain, headache, blood in urine, frequent urination, and kidney failure. The predisposing factors include age and family history. Treatment includes antihypertensive drugs and diuretics. The Polycystic Kidney Disease drugs in development market research report provide...
-
Product Insights
NewChronic Kidney Disease (Chronic Renal Failure) – Drugs In Development, 2024
Empower your strategies with our Chronic Kidney Disease (Chronic Renal Failure) – Drugs In Development, 2024 report and make more profitable business decisions. Chronic kidney disease is the slow loss of kidney function over time. Signs and symptoms of kidney disease include nausea, vomiting, loss of appetite, fatigue and weakness, sleep problems, hiccups, and swelling of feet and ankles. The predisposing factors include age, diabetes, high blood pressure, heart disease, smoking, obesity, and high cholesterol. The Chronic Kidney Disease (Chronic Renal...
-
Analyst Opinions
Tech, Genes, and Beyond – Startup Transforming Biotech
Biotech Startups Overview Biotech breakthroughs drive cost savings, provide competitive advantages, and showcase efficiency across industries through streamlined manufacturing, custom product development, and resilient supply chains. Biotech advancements are also reshaping the fields of medicine, agriculture, and industry. The following are some of the key highlights of the biotech startups trend analysis: Startups are leading the way for biotechnology advancements. Healthcare demands, government support, and technological breakthroughs are driving the market. AI integration is driving progress in DNA sequencing, drug...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – MZE-001 in Pompe Disease
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - MZE-001 in Pompe Disease report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.MZE-001 in Pompe Disease Drug Details:MZE-001 is under development for the treatment of...
-
Product Insights
Matas Homes – MAZE Condominiums Development – Ontario
Equip yourself with the essential tools needed to make informed and profitable decisions with our Matas Homes - MAZE Condominiums Development - Ontario report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep into the...
-
Company Profile
Thompson Creek Metals Co Inc – Company Profile
Thompson Creek Metals Co Inc (TCM) is a mining and exploration company. The company is engaged in the acquisition, exploration, development, and production of molybdenum, copper, and gold. The company owns and operates Thompson Creek open-pit molybdenum mine and concentrator in Idaho, the US; and Endako molybdenum mine and concentrator and Mount Milligan Mine copper and gold mine in British Columbia Canada. In addition, TMC also owns and operates a metallurgical facility in Pennsylvania, the US. The company also owns...
Add to Basket -
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – MZE-001
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry MZE-001 Drug Details MZE-001 is under development for the treatment of Pompe disease. It...
-
Product Insights
Amyotrophic Lateral Sclerosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
The symptoms of amyotrophic lateral sclerosis include difficulty breathing, difficulty swallowing, head drop due to weakness of the neck muscles, muscle cramps, speech problems, such as a slow or abnormal speech pattern (slurring of words), voice changes, hoarseness, weight loss. The Amyotrophic Lateral Sclerosis pipeline market research report provides comprehensive information on the therapeutics under development for Amyotrophic Lateral Sclerosis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type....